{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:54:38Z","timestamp":1790423678920,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T00:00:00Z","timestamp":1600819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T00:00:00Z","timestamp":1600819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In the era of hyper-ageing, Creutzfeldt\u2013Jakob disease (CJD) can become more prevalent as an important cause of dementia. This study aimed to evaluate the trends in crude and age-adjusted CJD-associated mortality and incidence rates in Japan using national vital statistics data on CJD-associated deaths among individuals aged over 50\u00a0years, as well as the government-funded nationwide CJD surveillance data (pertaining to the years 2005\u20132014) in Japan. The data were analysed using the Joinpoint Regression Program to estimate the long-term trends and average annual percentage changes (AAPCs). Overall, the AAPCs of age-adjusted CJD-associated mortality rates rose significantly over the study period (3.2%; 95% confidence interval [CI] 1.4\u20135.1%). The AAPC of the age-adjusted incidence rates also increased (overall 6.4%; 95% CI 4.7\u20138.1%). The CJD-associated increases in the mortality and incidence rates were especially prominent among adults over the age of 70\u00a0years.\u00a0Given this trend in aging of population, the disease burden of CJD will continue to increase in severity. Our findings thus recommend that policymakers be aware of the importance of CJD and focus on preparing to address the increasing prevalence of dementia.<\/jats:p>","DOI":"10.1038\/s41598-020-72519-0","type":"journal-article","created":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T10:03:36Z","timestamp":1600855416000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["A nationwide trend analysis in the incidence and mortality of Creutzfeldt\u2013Jakob disease in Japan between 2005 and 2014"],"prefix":"10.1038","volume":"10","author":[{"given":"Yoshito","family":"Nishimura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ko","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Koyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideharu","family":"Hagiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumio","family":"Otsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,23]]},"reference":[{"key":"72519_CR1","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1086\/432726","volume":"41","author":"ED Belay","year":"2005","unstructured":"Belay, E. D., Holman, R. C. & Schonberger, L. B. Creutzfeldt\u2013Jakob disease surveillance and diagnosis. Clin. Infect. Dis. 41, 834\u2013836. https:\/\/doi.org\/10.1086\/432726 (2005).","journal-title":"Clin. Infect. Dis."},{"key":"72519_CR2","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/jmv.24004","volume":"87","author":"J Lee","year":"2015","unstructured":"Lee, J. et al. Review: Laboratory diagnosis and surveillance of Creutzfeldt\u2013Jakob disease. J. Med. Virol. 87, 175\u2013186. https:\/\/doi.org\/10.1002\/jmv.24004 (2015).","journal-title":"J. Med. Virol."},{"key":"72519_CR3","first-page":"123","volume":"81","author":"PG Smith","year":"2003","unstructured":"Smith, P. G. The epidemics of bovine spongiform encephalopathy and variant Creutzfeldt\u2013Jakob disease: Current status and future prospects. Bull. World Health Organ. 81, 123\u2013130 (2003).","journal-title":"Bull. World Health Organ."},{"key":"72519_CR4","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1212\/01.wnl.0000036913.87823.d6","volume":"60","author":"ED Belay","year":"2003","unstructured":"Belay, E. D., Maddox, R. A., Gambetti, P. & Schonberger, L. B. Monitoring the occurrence of emerging forms of Creutzfeldt\u2013Jakob disease in the United States. Neurology 60, 176\u2013181. https:\/\/doi.org\/10.1212\/01.wnl.0000036913.87823.d6 (2003).","journal-title":"Neurology"},{"key":"72519_CR5","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s10654-007-9146-x","volume":"22","author":"JC Abrahantes","year":"2007","unstructured":"Abrahantes, J. C. et al. Classification of sporadic Creutzfeldt\u2013Jakob disease based on clinical and neuropathological characteristics. Eur. J. Epidemiol. 22, 457\u2013465. https:\/\/doi.org\/10.1007\/s10654-007-9146-x (2007).","journal-title":"Eur. J. Epidemiol."},{"key":"72519_CR6","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/s0531-5565(01)00219-4","volume":"37","author":"GG Kovacs","year":"2002","unstructured":"Kovacs, G. G. & Budka, H. Aging, the brain and human prion disease. Exp. Gerontol. 37, 603\u2013605. https:\/\/doi.org\/10.1016\/s0531-5565(01)00219-4 (2002).","journal-title":"Exp. Gerontol."},{"key":"72519_CR7","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3389\/fcell.2014.00044","volume":"2","author":"L Gasperini","year":"2014","unstructured":"Gasperini, L. & Legname, G. Prion protein and aging. Front. Cell Dev. Biol. 2, 44. https:\/\/doi.org\/10.3389\/fcell.2014.00044 (2014).","journal-title":"Front. Cell Dev. Biol."},{"key":"72519_CR8","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1007\/s00415-008-0900-0","volume":"255","author":"K Stoeck","year":"2008","unstructured":"Stoeck, K. et al. Heightened incidence of sporadic Creutzfeldt\u2013Jakob disease is associated with a shift in clinicopathological profiles. J. Neurol. 255, 1464\u20131472. https:\/\/doi.org\/10.1007\/s00415-008-0900-0 (2008).","journal-title":"J. Neurol."},{"key":"72519_CR9","unstructured":"United Nations, Department of Economic and Social Affairs, Population Division. World Population Ageing 2019: Highlights (ST\/ESA\/SER.A\/430). https:\/\/www.un.org\/en\/development\/desa\/population\/publications\/pdf\/ageing\/WorldPopulationAgeing2019-Highlights.pdf (2019)."},{"key":"72519_CR10","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.33321\/cdi.2019.43.35","volume":"43","author":"C Stehmann","year":"2018","unstructured":"Stehmann, C. et al. Creutzfeldt\u2013Jakob disease surveillance in Australia: Update to 31 December 2018. Commun. Dis. Intell. 43, 2019. https:\/\/doi.org\/10.33321\/cdi.2019.43.35 (2018).","journal-title":"Commun. Dis. Intell."},{"key":"72519_CR11","unstructured":"The Centers for Disease Control and Prevention. Occurrence and Transmission, Creutzfeldt\u2013Jakob Disease, Classic (CJD). https:\/\/www.cdc.gov\/prions\/cjd\/occurrence-transmission.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fprions%2Fcjd%2Foccurance-transmisison.html (2019)."},{"key":"72519_CR12","doi-asserted-by":"publisher","first-page":"e8521","DOI":"10.1371\/journal.pone.0008521","volume":"5","author":"RC Holman","year":"2010","unstructured":"Holman, R. C. et al. Human prion diseases in the United States. PLoS\u00a0One 5, e8521. https:\/\/doi.org\/10.1371\/journal.pone.0008521 (2010).","journal-title":"PLoS\u00a0One"},{"key":"72519_CR13","doi-asserted-by":"publisher","first-page":"182","DOI":"10.14745\/ccdr.v41i08a01","volume":"41","author":"MB Coulthart","year":"2015","unstructured":"Coulthart, M. B. et al. Creutzfeldt\u2013Jakob disease mortality in Canada, 1998 to 2013. Can. Commun. Dis. Rep. 41, 182\u2013191. https:\/\/doi.org\/10.14745\/ccdr.v41i08a01 (2015).","journal-title":"Can. Commun. Dis. Rep."},{"key":"72519_CR14","unstructured":"World Health Organization. Decade of Healthy Ageing 2020\u20132030. https:\/\/www.who.int\/docs\/default-source\/decade-of-healthy-ageing\/final-decade-proposal\/decade-proposal-final-apr2020-en.pdf?sfvrsn=b4b75ebc_3 (2020)."},{"key":"72519_CR15","unstructured":"United Nations, Department of Economic and Social Affairs,, Population Division. World Population Prospects 2019: Highlights (ST\/ESA\/SER.A\/423). https:\/\/population.un.org\/wpp\/Publications\/Files\/WPP2019_Highlights.pdf (2019)."},{"key":"72519_CR16","doi-asserted-by":"publisher","first-page":"65","DOI":"10.35772\/ghm.2019.01033","volume":"1","author":"H Matsumura","year":"2019","unstructured":"Matsumura, H. et al. G20 Okayama Health Ministers\u2019 Meeting: Lessons learned and way forward. Glob. Health Med. 1, 65\u201370. https:\/\/doi.org\/10.35772\/ghm.2019.01033 (2019).","journal-title":"Glob. Health Med."},{"key":"72519_CR17","unstructured":"Ministry of Health, Labour and Welfare of Japan. Okayama Declaration of the G20 Health Ministers, October 19\u201320, 2019. https:\/\/www.mhlw.go.jp\/seisakunitsuite\/bunya\/hokabunya\/kokusai\/g20\/health\/jp\/img\/G20Okayama_HM_EN.pdf (2019)."},{"key":"72519_CR18","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1159\/000126916","volume":"30","author":"Y Doi","year":"2008","unstructured":"Doi, Y. et al. Spatial clusters of Creutzfeldt\u2013Jakob disease mortality in Japan between 1995 and 2004. Neuroepidemiology 30, 222\u2013228. https:\/\/doi.org\/10.1159\/000126916 (2008).","journal-title":"Neuroepidemiology"},{"key":"72519_CR19","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2188\/jea.17.19","volume":"17","author":"Y Nakamura","year":"2007","unstructured":"Nakamura, Y., Watanabe, M., Nagoshi, K., Yamada, M. & Mizusawa, H. Geographic difference of mortality of Creutzfeldt\u2013Jakob disease in Japan. J. Epidemiol. 17, 19\u201324. https:\/\/doi.org\/10.2188\/jea.17.19 (2007).","journal-title":"J. Epidemiol."},{"key":"72519_CR20","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2188\/jea.17.133","volume":"17","author":"Y Doi","year":"2007","unstructured":"Doi, Y., Yokoyama, T., Sakai, M. & Nakamura, Y. Creutzfeldt\u2013Jakob disease mortality in Japan, 1979\u20132004: Analysis of national death certificate data. J. Epidemiol. 17, 133\u2013139. https:\/\/doi.org\/10.2188\/jea.17.133 (2007).","journal-title":"J. Epidemiol."},{"key":"72519_CR21","unstructured":"Creutzfeldt\u2013Jakob Disease International Surveillance Network. CJD Surveillance Data 1993\u20132018. https:\/\/www.eurocjd.ed.ac.uk\/surveillance%20data%201.html (2020)."},{"key":"72519_CR22","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.1016\/S1473-3099(19)30615-2","volume":"20","author":"L Uttley","year":"2020","unstructured":"Uttley, L., Carroll, C., Wong, R., Hilton, D. A. & Stevenson, M. Creutzfeldt\u2013Jakob disease: A systematic review of global incidence, prevalence, infectivity, and incubation. Lancet Infect. Dis. 20, e2\u2013e10. https:\/\/doi.org\/10.1016\/S1473-3099(19)30615-2 (2020).","journal-title":"Lancet Infect. Dis."},{"issue":"Suppl","key":"72519_CR23","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.21101\/cejph.a5277","volume":"26","author":"E Feketeova","year":"2018","unstructured":"Feketeova, E. et al. Creutzfeldt\u2013Jakob disease surveillance in Eastern Slovakia from 2004 to 2016. Cent. Eur. J. Public Health 26(Suppl), S37\u2013S41. https:\/\/doi.org\/10.21101\/cejph.a5277 (2018).","journal-title":"Cent. Eur. J. Public Health"},{"key":"72519_CR24","first-page":"155","volume":"67","author":"K Kolarova","year":"2018","unstructured":"Kolarova, K., Maresova, M., Mandakova, Z. & Kyncl, J. Prion diseases with a focus on Creutzfeldt\u2013Jakob disease, a summary of the incidence of Creutzfeldt\u2013Jakob disease in the Czech Republic over the last 17 years, 2000\u20132017. Epidemiol. Mikrobiol. Imunol. 67, 155\u2013160 (2018).","journal-title":"Epidemiol. Mikrobiol. Imunol."},{"key":"72519_CR25","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1093\/brain\/awh249","volume":"127","author":"M Pocchiari","year":"2004","unstructured":"Pocchiari, M. et al. Predictors of survival in sporadic Creutzfeldt\u2013Jakob disease and other human transmissible spongiform encephalopathies. Brain 127, 2348\u20132359. https:\/\/doi.org\/10.1093\/brain\/awh249 (2004).","journal-title":"Brain"},{"key":"72519_CR26","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1093\/brain\/awm063","volume":"130","author":"U Heinemann","year":"2007","unstructured":"Heinemann, U. et al. Creutzfeldt\u2013Jakob disease in Germany: A prospective 12-year surveillance. Brain 130, 1350\u20131359. https:\/\/doi.org\/10.1093\/brain\/awm063 (2007).","journal-title":"Brain"},{"key":"72519_CR27","unstructured":"Statistics Bureau of Japan. Statistical Handbook of Japan 2019. https:\/\/www.stat.go.jp\/english\/data\/handbook\/c0117.html (2020)."},{"key":"72519_CR28","unstructured":"Creutzfeldt\u2013Jakob Disease Surveillance Committee. The Surveillance Result of Prion Disease [Article in Japanese]. https:\/\/www.jichi.ac.jp\/dph\/wp-dph\/wp-content\/uploads\/2020\/05\/d5e991d6e9d3e2af053d3e318c510264.pdf (2020)."},{"key":"72519_CR29","doi-asserted-by":"publisher","first-page":"e74244","DOI":"10.1371\/journal.pone.0074244","volume":"8","author":"F Agostini","year":"2013","unstructured":"Agostini, F. et al. Prion protein accumulation in lipid rafts of mouse aging brain. PLoS\u00a0One 8, e74244. https:\/\/doi.org\/10.1371\/journal.pone.0074244 (2013).","journal-title":"PLoS\u00a0One"},{"key":"72519_CR30","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1128\/JVI.02936-13","volume":"88","author":"B Molloy","year":"2014","unstructured":"Molloy, B. & McMahon, H. E. A cell-biased effect of estrogen in prion infection. J. Virol. 88, 1342\u20131353. https:\/\/doi.org\/10.1128\/JVI.02936-13 (2014).","journal-title":"J. Virol."},{"key":"72519_CR31","unstructured":"World Health Organization. Global Action Plan on the Public Health Response to Dementia 2017\u20132025. (2017)."},{"key":"72519_CR32","unstructured":"World Health Organization. Dementia. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/dementia (2020)."},{"key":"72519_CR33","doi-asserted-by":"publisher","first-page":"e026733","DOI":"10.1136\/bmjopen-2018-026733","volume":"9","author":"T Nakabe","year":"2019","unstructured":"Nakabe, T. et al. Classification tree model of the personal economic burden of dementia care by related factors of both people with dementia and caregivers in Japan: A cross-sectional online survey. BMJ Open 9, e026733. https:\/\/doi.org\/10.1136\/bmjopen-2018-026733 (2019).","journal-title":"BMJ Open"},{"key":"72519_CR34","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1017\/S1041610215001647","volume":"28","author":"A Uflacker","year":"2016","unstructured":"Uflacker, A., Edmondson, M. C., Onyike, C. U. & Appleby, B. S. Caregiver burden in atypical dementias: Comparing frontotemporal dementia, Creutzfeldt\u2013Jakob disease, and Alzheimer\u2019s disease. Int. Psychogeriatr. 28, 269\u2013273. https:\/\/doi.org\/10.1017\/S1041610215001647 (2016).","journal-title":"Int. Psychogeriatr."},{"key":"72519_CR35","unstructured":"Ministry of Health, Labour and Welfare Japan. Vital Statistics. https:\/\/www.mhlw.go.jp\/english\/database\/db-hw\/vs01.html (2020)."},{"key":"72519_CR36","unstructured":"Ministry of Internal Affairs and Communications Japan. e-Stat, Statistics of Japan. https:\/\/www.e-stat.go.jp\/en (2020)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72519-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72519-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72519-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T19:03:50Z","timestamp":1670353430000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72519-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,23]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["72519"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-72519-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,23]]},"assertion":[{"value":"25 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15509"}}